Literature DB >> 8467493

Entry of protein toxins in polarized epithelial cells.

E L Melby1, J Jacobsen, S Olsnes, K Sandvig.   

Abstract

The action of a number of toxins used in the formation of immunotoxins was studied in polarized cells. Diphtheria toxin inhibited protein synthesis most efficiently when added to the basolateral side of the kidney cells, MDCK-I, MDBK and Pt K2, and the colon carcinoma cell Caco-2. Similar findings were made with Pseudomonas aeruginosa exotoxin A in MDCK-I, Pt K2, and Caco-2 cells, and with modeccin and volkensin in MDCK-I cells. In accordance with the toxicity data, diphtheria toxin bound specifically to the basolateral side of MDCK-I cells but not to the apical side. On the other hand, in the trophoblastic BeWo cell line there was little or no difference in the toxic effect of P. aeruginosa exotoxin A and modeccin added to the two sides. The plant toxins ricin and abrin and the bacterial Shigella toxin inhibited protein synthesis approximately equally well in all cell lines tested whether they were added apically or basolaterally. The results indicate that protein toxins are able to enter cells from both the apical and basolateral sides provided receptors are present. The consequences for the preparation of immunotoxins are discussed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8467493

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   13.312


  9 in total

1.  Cell polarization is required for ricin sensitivity in a Caco-2 cell line selected for ricin resistance.

Authors:  M R Jackman; J A Ellis; S R Gray; W Shurety; J P Luzio
Journal:  Biochem J       Date:  1999-07-15       Impact factor: 3.857

2.  Rho protein regulates tight junctions and perijunctional actin organization in polarized epithelia.

Authors:  A Nusrat; M Giry; J R Turner; S P Colgan; C A Parkos; D Carnes; E Lemichez; P Boquet; J L Madara
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-07       Impact factor: 11.205

Review 3.  Enterohemorrhagic Escherichia coli and a Fresh View on Shiga Toxin-Binding Glycosphingolipids of Primary Human Kidney and Colon Epithelial Cells and Their Toxin Susceptibility.

Authors:  Johanna Detzner; Gottfried Pohlentz; Johannes Müthing
Journal:  Int J Mol Sci       Date:  2022-06-21       Impact factor: 6.208

4.  Retrograde transport from the Golgi complex to the ER of both Shiga toxin and the nontoxic Shiga B-fragment is regulated by butyric acid and cAMP.

Authors:  K Sandvig; M Ryd; O Garred; E Schweda; P K Holm; B van Deurs
Journal:  J Cell Biol       Date:  1994-07       Impact factor: 10.539

Review 5.  Mimicking the host and its microenvironment in vitro for studying mucosal infections by Pseudomonas aeruginosa.

Authors:  Aurélie Crabbé; Maria A Ledesma; Cheryl A Nickerson
Journal:  Pathog Dis       Date:  2014-05-23       Impact factor: 3.166

6.  Membrane assembly of Shiga toxin glycosphingolipid receptors and toxin refractiveness of MDCK II epithelial cells.

Authors:  Nadine Legros; Gottfried Pohlentz; Daniel Steil; Ivan U Kouzel; Ivan Liashkovich; Alexander Mellmann; Helge Karch; Johannes Müthing
Journal:  J Lipid Res       Date:  2018-06-04       Impact factor: 5.922

Review 7.  Molecular Biology of Escherichia Coli Shiga Toxins' Effects on Mammalian Cells.

Authors:  Christian Menge
Journal:  Toxins (Basel)       Date:  2020-05-23       Impact factor: 4.546

8.  Cholix protein domain I functions as a carrier element for efficient apical to basal epithelial transcytosis.

Authors:  Alistair Taverner; Julia MacKay; Floriane Laurent; Tom Hunter; Keyi Liu; Khushdeep Mangat; Lisa Song; Elbert Seto; Sally Postlethwaite; Aatif Alam; Apurva Chandalia; Minji Seung; Mazi Saberi; Weijun Feng; Randall J Mrsny
Journal:  Tissue Barriers       Date:  2020-01-13

9.  Level of receptor-associated protein moderates cellular susceptibility to pseudomonas exotoxin A.

Authors:  D Mucci; J Forristal; D Strickland; R Morris; D Fitzgerald; C B Saelinger
Journal:  Infect Immun       Date:  1995-08       Impact factor: 3.609

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.